Xiao-Ai-Ping, a TCM injection, enhances the antigrowth effects of cisplatin on lewis lung cancer cells through promoting the infiltration and function of CD8+ T Lymphocytes

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Li, Wanshuai ^a   Yang, Yang ^a   Ouyang, Zijun ^a   Zhang, Qi ^a   Wang, Lu ^a   Tao, Feifei ^a   Shu, Yongqian ^b   Gu, Yanhong ^b   Xu, Qiang ^a   Sun, Yang ^a  

^a NANJING UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHINESE DRUG; CISPLATIN; CYCLINE; GAMMA INTERFERON; GRANZYME B; MESSENGER RNA; PERFORIN; UNCLASSIFIED DRUG; XIAO AI PING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CHINESE MEDICINE; CONTROLLED STUDY; DRUG POTENTIATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CANCER; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPLEEN WEIGHT; UPREGULATION;

EID: 84881522451     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/879512     Document Type: Article

References (38)

1. Foulds G. A., Radons J., Kreuzer M., Multhoff G., Pockley A. G., Influence of tumors on protective anti-tumor immunity and the effects of irradiation. Frontiers in Oncology 2013 3 article 14
2. Chen G., Emens L. A., Chemoimmunotherapy: reengineering tumor immunity. Cancer Immunology, Immunotherapy 2013 62 2 203 216 10.1007/s00262-012-1388-0
3. Mellman I., Coukos G., Dranoff G., Cancer immunotherapy comes of age. Nature 2011 480 7378 480 489 2-s2.0-84255197842 10.1038/nature10673
4. Topalian S. L., Hodi F. S., Brahmer J. R., Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. The New England Journal of Medicine 2012 366 26 2443 2454 10.1056/NEJMoa1200690
5. Brahmer J. R., Tykodi S. S., Chow L. Q., Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. The New England Journal of Medicine 2012 366 26 2455 2465 10.1056/NEJMoa1200694
6. + T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma. PLoS ONE 2013 8 1 e47434 10.1371/journal.pone.0047434
7. Higham E. M., Shen C., Wittrup K. D., Chen J., Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model. Journal of Immunology 2010 184 11 5954 5958 2-s2.0-77953431574 10.4049/jimmunol.1000265
8. Wu R., Forget M. A., Chacon J., Bernatchez C., Haymaker C., Chen J. Q., Hwu P., Radvanyi L. G., Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook. Cancer Journal 2012 18 2 160 175 2-s2.0-84859471907 10.1097/PPO.0b013e31824d4465
9. + CTLs in a perforin/granzyme-mediated and IFN- γ -dependent manner: application of Trp2180-188 peptides. Cancer Immunology, Immunotherapy 2012 61 10 1671 1682 2-s2.0-84857480239 10.1007/s00262-012-1214-8
10. + T cells, NK cells and IFN- γ are important for control of tumor with downregulated MHC class I expression by DNA vaccination. Gene Therapy 2003 10 16 1311 1320 2-s2.0-0041524186 10.1038/sj.gt.3301982 (Pubitemid 36987121)
11. Hollenbaugh J. A., Dutton R. W., IFN- γ or CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor. Journal of Immunology 2006 177 5 3004 3011 2-s2.0-33747803970 (Pubitemid 44277816)
12. Huang Z., Lin H., Wang Y., Cao Z., Lin W., Chen Q., Studies on the anti-angiogenic effect of Marsdenia tenacissima extract in vitro and in vivo. Oncology Letters 2013 5 3 917 922
13. Saleh E. M., El-Awady R. A., Anis N., Predictive markers for the response to 5-fluorouracil therapy in cancer cells: constant-field gel electrophoresis as a tool for prediction of response to 5-fluorouracil-based chemotherapy. Oncology Letters 2013 5 1 321 327
14. Watanabe T., Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer. Breast Cancer 2013 10.1007/s12282-013-0451-9
15. Kang T. H., Mao C. P., Lee S. Y., Chemotherapy acts as an adjuvant to convert the tumor microenvironment into a highly permissive state for vaccination-induced antitumor immunity. Cancer Research 2013 73 8 2493 2504 10.1158/0008-5472.CAN-12-4241
16. Murugaiyan G., Saha B., IL-27 in tumor immunity and immunotherapy. Trends in Molecular Medicine 2013 19 2 108 116 10.1016/j.molmed.2012.12.002
17. Pasero C., Olive D., Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity. Immunology Letters 2013 151 1-2 71 75 10.1016/j.imlet.2013.01.008
18. Mehta R. G., Murillo G., Naithani R., Peng X., Cancer chemoprevention by natural products: how far have we come? Pharmaceutical Research 2010 27 6 950 961 2-s2.0-77953205368 10.1007/s11095-010-0085-y
19. Ji H. F., Li X. J., Zhang H. Y., Natural products and drug discovery: can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Reports 2009 10 3 194 200 2-s2.0-61849148824 10.1038/embor.2009.12
20. Gray A. I., Igoli J. O., Edrada-Ebel R., Natural products isolation in modern drug discovery programs. Methods in Molecular Biology 2012 864 515 534 2-s2.0-84859871465 10.1007/978-1-61779-624-1-20
21. Mondal S., Bandyopadhyay S., Ghosh M. K., Mukhopadhyay S., Roy S., Mandal C., Natural products: promising resources for cancer drug discovery. Anti-Cancer Agents in Medicinal Chemistry 2012 12 1 49 75 2-s2.0-84855281811
22. Tu Y., Yan B., High-throughput fractionation of natural products for drug discovery. Methods in Molecular Biology 2012 918 117 126 10.1007/978-1-61779- 995-2-9
23. Vasilevich N. I., Kombarov R. V., Genis D. V., Kirpichenok M. A., Lessons from natural products chemistry can offer novel approaches for synthetic chemistry in drug discovery. Journal of Medicinal Chemistry 2012 55 16 7003 7009 10.1021/jm300344v
24. Zhang H., Tan A. M., Zhang A. Y., Chen R., Yang S., Huang X., Five new C21 steroidal glycosides from the stems of Marsdenia tenacissima. Steroids 2010 75 2 176 183 2-s2.0-73549087406 10.1016/j.steroids.2009.11.003
25. Qiu S. X., Luo S. Q., Lin L. Z., Cordell G. A., Further polyoxypregnanes from Marsdenia tenacissima. Phytochemistry 1996 41 5 1385 1388 2-s2.0-0030111383
26. Wang W. Y., Zhou Y., Zhang X. J., Gao T. H., Luo Z. F., Liu M. Y., A random study of xiaoaiping injection combined with chemotherapy on the treatment of advanced non-small cell lung cancer Chinese Clinical Oncology 2009 14 936 938
27. Huang Z. Q., Tan H., Wang C. Y., Zhang H. Z., Liu D., Zhou C. Z., Liu X., Clinical research of combined xiaoaiping injection with chemotherapy on advanced non-small cell lung cancer Chinese Clinical Oncology 2007 12 97 99
28. Ken W., Zhixiong G., Xiaoaiping injection combining with NP regiment in the treatment of 56 patients with advanced lung cancer Journal of Basic and Clinical Oncology 2009 22 47 48
29. Li W., Song R., Fang X., Wang L., Chen W., Tang P., Yu B., Sun Y., Xu Q., SBF-1, a synthetic steroidal glycoside, inhibits melanoma growth and metastasis through blocking interaction between PDK1 and AKT3. Biochemical Pharmacology 2012 84 2 172 181 2-s2.0-84860572883 10.1016/j.bcp.2012.04.006
30. Novitskiy S. V., Csiki I., Huang Y., Johnson D. H., Harth E. M., Carbone D. P., Dikov M. M., Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cells. Journal of Thoracic Oncology 2010 5 9 1410 1415 2-s2.0-77956265222 10.1097/JTO.0b013e3181e59c24
31. Song S., Xiong C., Lu W., Ku G., Huang G., Li C., Apoptosis imaging probe predicts early chemotherapy response in preclinical models: a comparative study with 18F-FDG PET. Journal of Nuclear Medicine 2013 54 1 104 110 10.2967/jnumed.112.109397
32. Kang J. S., Kang H. G., Park Y. I., Lee H., Park K., Lee Y. S., Kim S., Ryu D. Y., Expression of epithelial cell adhesion molecule and proliferating cell nuclear antigen in diethylnitrosamine-induced hepatocarcinogenesis in mice. Experimental and Therapeutic Medicine 2013 5 1 138 142 10.3892/etm.2012.751
33. Lazrek Y., Dubreuil O., Garambois V., Gaborit N., Larbouret C., le Clorennec C., Thomas G., Leconet W., Jarlier M., Pugnière M., Vié N., Robert B., Monnet C., Bouayadi K., Kharrat H., Mondon P., Pèlegrin A., Chardès T., Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation. Neoplasia 2013 15 3 335 347
34. Gopalan A., Yu W., Sanders B. G., Kline K., Simvastatin inhibition of mevalonate pathway induces apoptosis in human breast cancer cells via activation of JNK/CHOP/DR5 signaling pathway. Cancer Letters 2013 329 1 9 16 10.1016/j.canlet.2012.08.031
35. Ryder C. B., McColl K., Distelhorst C. W., Acidosis blocks CCAAT/enhancer-binding protein homologous protein (CHOP)- and c-Jun-mediated induction of p53-upregulated mediator of apoptosis (PUMA) during amino acid starvation. Biochemical and Biophysical Research Communications 2013 430 4 1283 1288 10.1016/j.bbrc.2012.11.136
36. + tumor-infiltrating T cells are trapped in the tumor-dendritic cell network. Neoplasia 2013 15 1 85 94
37. + T cell immunity for rapid protective vaccination in a murine model for human smallpox. PLoS Pathogens 2012 8 3 e1002557 10.1371/journal.ppat. 1002557
38. + T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi -elicited cardiomyopathy. PLoS Pathogens 2012 8 4 e1002645 10.1371/journal.ppat.1002645